SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Arthur Radley who wrote (23872)6/3/2007 3:25:25 PM
From: Biomaven  Respond to of 52153
 
<EXEL>

So how come the pre-ASCO traders with access to the abstracts didn't hit EXEL hard earlier?

I suppose the AE's might not have been all revealed in the Abstract - always worth remembering that the abstracts are submitted quite a while back, and so stuff (both good and bad) can happen in the interim.

Peter

P.S. Thanks for the good wishes on the kids - I'm certainly not counting any retirement allowance just yet...

Peter



To: Arthur Radley who wrote (23872)6/3/2007 7:02:46 PM
From: LJM  Respond to of 52153
 
XL999 news isn't really "new." The FDA put this trial on partial hold back in December/06 for serious adverse cardiac events.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News